Vimarsana
Biggest News Aggregation in the World

Mitchells Goldberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitchells Goldberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitchells Goldberg Today - Breaking & Trending Today

Whistleblowers get new chance to fine-tune Genesis allegations - Vimarsana News

Whistleblowers get new chance to fine-tune Genesis allegations

More than eight years after first alleging False Claims Act violations against Genesis Healthcare and Sun Healthcare, a group of whistleblowers was given more time to refine its case.

UPenn says its faculty's lawsuit over Congressional anti-Semitism investigation is meritless - Vimarsana News

UPenn says its faculty's lawsuit over Congressional anti-Semitism investigation is meritless

PHILADELPHIA – Prior to filing a motion to dismiss, counsel for the University of Pennsylvania have countered litigation from a group of the school’s professors – a suit which alleged the school’s cooperation with Congressional investigations into anti-Semitic activity on campus is tantamount to a modern form of “McCarthyism” – with an argument that the case lacks legal standing.

Philadelphia's Juvenile Probation Dept. gets partial dismissal of counts in class action sexual abuse suit - Vimarsana News

Philadelphia's Juvenile Probation Dept. gets partial dismissal of counts in class action sexual abuse suit

PHILADELPHIA – In a class action, sexual abuse lawsuit brought by seven former residents of The Summit Academy, Philadelphia’s Juvenile Probation Department has received dismissal of certain federal civil rights and state-law claims lodged against it.

Arbutus Vs. Moderna Patent Dispute Set for Continuing Discovery - Arbutus Biopharma (NASDAQ:ABUS), Moderna (NASDAQ:MRNA) - Vimarsana News

Arbutus Vs. Moderna Patent Dispute Set for Continuing Discovery - Arbutus Biopharma (NASDAQ:ABUS), Moderna (NASDAQ:MRNA)

Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.

Arbutus Stock Soars 20%, Covid Patent Claim Against Moderna Proceeds - Arbutus Biopharma (NASDAQ:ABUS) - Vimarsana News

Arbutus Stock Soars 20%, Covid Patent Claim Against Moderna Proceeds - Arbutus Biopharma (NASDAQ:ABUS)

Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.